This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-estimates: Archive
Yext (YEXT) Q3 Earnings Beat Estimates
by Zacks Equity Research
Yext (YEXT) delivered earnings and revenue surprises of +16.67% and -0.72%, respectively, for the quarter ended October 2025. Do the numbers hold clues to what lies ahead for the stock?
YEXTNegative Net Change SKILPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Certara (CERT): Time to Buy?
by Zacks Equity Research
Certara, Inc. (CERT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
CERTNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Rising for AvePoint (AVPT): Will It Gain?
by Zacks Equity Research
AvePoint, Inc. (AVPT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
AVPTPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Mazda Motor (MZDAY) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Mazda Motor (MZDAY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MZDAYNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Marvell (MRVL) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Marvell (MRVL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MRVLNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Nokia (NOK) a New Buy Stock
by Zacks Equity Research
Nokia (NOK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NOKPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Andritz (ADRZY) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Andritz (ADRZY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ADRZYNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Tilly's (TLYS) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Tilly's (TLYS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
TLYSNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Southern Missouri Bancorp (SMBC) Rating Upgrade to Buy
by Zacks Equity Research
Southern Missouri Bancorp (SMBC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
SMBCPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
CorMedix (CRMD) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
CorMedix (CRMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
CRMDPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Donaldson (DCI) Rating Upgrade to Buy
by Zacks Equity Research
Donaldson (DCI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
DCINegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Sally Beauty (SBH) Upgraded to Buy: Here's Why
by Zacks Equity Research
Sally Beauty (SBH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SBHNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why
by Zacks Equity Research
PDS Biotechnology (PDSB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
PDSBPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
New to Investing? This 1 Business Services Stock Could Be the Perfect Starting Point
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
ROLNegative Net Change
earnings-estimates growth-investing zacks-consensus-estimate zacks-rank
Earnings Growth & Price Strength Make GE HealthCare Technologies (GEHC) a Stock to Watch
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
GEHCNegative Net Change
earnings-estimates growth-investing zacks-consensus-estimate zacks-rank
Earnings Growth & Price Strength Make CBRE Group (CBRE) a Stock to Watch
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
CBRENegative Net Change
earnings-estimates growth-investing zacks-consensus-estimate zacks-rank
Stay Ahead of the Game With Lovesac (LOVE) Q3 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Lovesac (LOVE) for the quarter ended October 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
LOVENegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Insights Into Ciena (CIEN) Q4: Wall Street Projections for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Ciena (CIEN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended October 2025.
CIENPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Seeking Clues to Lululemon (LULU) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Lululemon (LULU), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended October 2025.
LULUNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Why Robinhood Markets (HOOD) Might be Well Poised for a Surge
by Zacks Equity Research
Robinhood Markets, Inc. (HOOD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
HOODPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Can MongoDB (MDB) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
MongoDB (MDB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
MDBPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Surging Earnings Estimates Signal Upside for Aveanna (AVAH) Stock
by Zacks Equity Research
Aveanna Healthcare (AVAH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
AVAHNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why Credo Technology Group (CRDO) Might be Well Poised for a Surge
by Zacks Equity Research
Credo Technology Group Holding Ltd. (CRDO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
CRDOPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Surging Earnings Estimates Signal Upside for Pagaya Technologies Ltd. (PGY) Stock
by Zacks Equity Research
Pagaya Technologies Ltd. (PGY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
PGYNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Surging Earnings Estimates Signal Upside for Amicus Therapeutics (FOLD) Stock
by Zacks Equity Research
Amicus Therapeutics (FOLD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
FOLDNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank